Allianz Asset Management
RCUS icon

Allianz Asset Management’s Arcus Biosciences RCUS Stock Holding History

Allianz Asset Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-24,500
Closed -$375K – 2307
2024
Q3 		$375K Sell
24,500
-42,700
-64% -$673K ﹤0.01% 1932
2024
Q2 		$1.02M Sell
67,200
-31,100
-32% -$502K ﹤0.01% 1580
2024
Q1 		$1.86M Buy
98,300
+75,000
+322% +$1.3M ﹤0.01% 1206
2023
Q4 		$445K Sell
23,300
-13,700
-37% -$219K ﹤0.01% 1892
2023
Q3 		$664K Sell
37,000
-200
-0.5% -$4.02K ﹤0.01% 1832
2023
Q2 		$756K Sell
37,200
-33,400
-47% -$636K ﹤0.01% 1625
2023
Q1 		$1.29M Buy
+70,600
New +$1.35M ﹤0.01% 1568
2021
Q1 		– Sell
-7,900
Closed -$205K – 2269
2020
Q4 		$205K Sell
7,900
-45,105
-85% -$1.09M ﹤0.01% 1806
2020
Q3 		$908K Sell
53,005
-48,120
-48% -$1.08M ﹤0.01% 1452
2020
Q2 		$2.5M Buy
101,125
+403
+0.4% +$10.9K ﹤0.01% 1518
2020
Q1 		$1.4M Buy
+100,722
New +$1.25M ﹤0.01% 1656

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Allianz Asset Management's RCUS Position: Q4 2024 in Review

Allianz Asset Management sold out of Arcus Biosciences (RCUS) in Q4 2024, closing a stake of 24,500 shares — an estimated $375K sold.

Allianz Asset Management first reported a position in RCUS in Q1 2020 and held it in 11 quarters. The position peaked at $2.5M in Q2 2020. 186 funds tracked by Wall St. Rank hold RCUS as of Q4 2024.

  • Allianz Asset Management reported no remaining Arcus Biosciences position as of Q4 2024 after selling out during the quarter.
  • Allianz Asset Management sold 24,500 Arcus Biosciences shares in Q4 2024, an estimated $375K.
  • Allianz Asset Management first reported a position in Arcus Biosciences in Q1 2020 and held it in 11 quarters.
  • Allianz Asset Management's Arcus Biosciences position peaked at $2.5M in Q2 2020.
  • 186 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2024.

Based on Allianz Asset Management's 13F filing for Q4 2024, filed 3 Feb 2025.